Compounds and methods for treating influenza
This invention is directed to methods for treating and preventing influenza infection by inhibiting influenza virus HA maturation processes employing compounds of formula I. It is also directed to combinations for treating and preventing influenza infection comprising compounds of formula I and other agents.
1. A method of treating a viral infection which is caused by a virus selected from Parainfluenza virus, Coronavirus, Adenovirus and Respiratory syncytial virus comprising:
administering to a subject in need thereof an affective amount of nitazoxanide or a pharmaceutically acceptable salt thereof.
2. The method of claim 1 , wherein the viral infection is caused by the Parainfluenza virus.
3. The method of claim 1 , wherein the viral infection is caused by the Coronavirus.
4. The method of claim 1 , wherein the viral infection is caused by the Adenovirus.
5. The method of claim 1 , wherein the viral infection is caused by the Respiratory syncytial virus.
6. The method of claim 1 , wherein the subject has influenza-like symptoms.
7. The method of claim 1 , wherein said administering is performed orally.
8. The method of claim 7 , wherein said administering comprises administering the nitazoxanide or a pharmaceutically acceptable salt thereof at a dose of 300 mg or 600 mg twice daily.
9. The method of claim 8 , wherein said administering is performed for 5 days.
10. The method of claim 1 , wherein the nitazoxanide or a pharmaceutically acceptable salt thereof is administered as modified release bi-layer tablet.
11. The method of claim 10 , wherein the nitazoxanide or a pharmaceutically acceptable salt thereof is administered in 100 mg, 200 mg, 300 mg, 400 mg, 500 mg or 600 mg doses twice daily.
12. The method of claim 11 , wherein said administering is performed for 5 days.